ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
101.80
0.30
(0.30%)
Closed 26 December 3:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
101.80
Bid
101.80
Offer
102.40
Volume
20,139
101.70 Day's Range 102.70
88.25 52 Week Range 111.50
Market Cap
Previous Close
101.50
Open
101.70
Last Trade
129
@
101.8
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
104,826
Shares Outstanding
117,946,146
Dividend Yield
0.83%
PE Ratio
33.58
Earnings Per Share (EPS)
3.03
Revenue
3.67B
Net Profit
357.6M

About Biomerieux

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Lyon, Rhone, Fra
Founded
-
Biomerieux is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker BIM. The last closing price for Biomerieux was 101.50 €. Over the last year, Biomerieux shares have traded in a share price range of 88.25 € to 111.50 €.

Biomerieux currently has 117,946,146 shares in issue. The market capitalisation of Biomerieux is 11.97 € billion. Biomerieux has a price to earnings ratio (PE ratio) of 33.58.

BIM Latest News

Oxford Nanopore and bioMérieux to Enter Into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics

Oxford Nanopore Technologies plc (LSE: ONT) (“Oxford Nanopore”), the company delivering a new generation of nanopore-based molecular sensing technology, and bioMérieux SA, a world leader in the...

Baxter and bioMérieux Announce CE Mark for NEPHROCLEAR™ CCL14 Test to Predict Persistent Severe Acute Kidney Injury

Reinforces Baxter and bioMérieux’s shared commitment to enhancing acute kidney injury (AKI) management through informed clinical decision-making and patient-centered approaches Aids hospitals in...

bioMérieux : Avis de mise à disposition des documents préparatoires à l’Assemblée générale mixte du 20 mai 2021

Regulatory News: Une Assemblée générale mixte des actionnaires de bioMérieux (Paris:BIM) (la « Société ») est convoquée le 20 mai 2021, à 14 heures, au 376, Chemin de l’Orme, 69280 Marcy...

bioMérieux : Informations mensuelles relatives au nombre total de droits de vote et d’actions prévues par l’article L. ...

Regulatory News: bioMérieux (Paris:BIM) : Code : BIM - Code ISIN : FR0013280286 Date d’arrêt des informations Nombre d’actions Nombre total de droits de vote   31/03/2021   118 361 220 Nombre...

bioMérieux Announces the CE Marking of TB IGRA® Test on VIDAS®

Regulatory News: Today marks World Tuberculosis (TB) Day and bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and...

bioMérieux reçoit une autorisation De Novo de la FDA pour le panel Respiratoire BIOFIRE® 2.1 (RP2.1) incluant le SARS-CoV-2

Regulatory News: bioMérieux (Paris:BIM), acteur majeur dans le domaine du diagnostic in vitro, annonce que sa filiale spécialisée dans les tests syndromiques des maladies infectieuses, BioFire...

bioMérieux : Communiqué de mise à disposition du Document d’enregistrement universel incluant le rapport financier annue...

Regulatory News: Le Document d’enregistrement universel incluant le rapport financier annuel au 31 décembre 2020 de bioMérieux (Paris:BIM) a été déposé auprès de l'Autorité des Marchés...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
110.992063492063100.8102.799.95118217101.82965128DE
43.93.9836567926597.9103.195.993793100.1276331DE
12-6.1-5.65338276182107.9110.495.9104826102.33482578DE
2612.9514.575126617988.85111.588.2594898101.39636365DE
520.90.891972249752100.9111.588.2597894100.02884327DE
156-21.8-17.6375404531123.6126.377.4810345096.72175136DE
26020.925.834363411680.9144.875116139102.74286549DE

BIM - Frequently Asked Questions (FAQ)

What is the current Biomerieux share price?
The current share price of Biomerieux is 101.80 €
How many Biomerieux shares are in issue?
Biomerieux has 117,946,146 shares in issue
What is the market cap of Biomerieux?
The market capitalisation of Biomerieux is EUR 11.97B
What is the 1 year trading range for Biomerieux share price?
Biomerieux has traded in the range of 88.25 € to 111.50 € during the past year
What is the PE ratio of Biomerieux?
The price to earnings ratio of Biomerieux is 33.58
What is the cash to sales ratio of Biomerieux?
The cash to sales ratio of Biomerieux is 3.27
What is the reporting currency for Biomerieux?
Biomerieux reports financial results in EUR
What is the latest annual turnover for Biomerieux?
The latest annual turnover of Biomerieux is EUR 3.67B
What is the latest annual profit for Biomerieux?
The latest annual profit of Biomerieux is EUR 357.6M
What is the registered address of Biomerieux?
The registered address for Biomerieux is CHEMIN DE L'ORME, MARCY L’ETOILE, LYON, RHONE, 69280
What is the Biomerieux website address?
The website address for Biomerieux is www.biomerieux.com
Which industry sector does Biomerieux operate in?
Biomerieux operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EIFDSTour Eiffel DS
0.0432 €
(800.00%)
89.74k
SEQUASequana medical NV
2.76 €
(33.33%)
1.64M
ALEUPEuroplasma
0.0484 €
(28.38%)
6.54M
ALPAUPaulic Meunerie SA
1.43 €
(16.26%)
17.14k
GNROGeNeuro SA
0.081 €
(15.38%)
330.33k
MLSMLSmalto
0.0125 €
(-32.43%)
50
ALVIAVialife Sa
13.30 €
(-27.72%)
7
MLMADMade
9.25 €
(-15.91%)
255
ALALOAcheterLouerFR
0.23 €
(-14.81%)
3.92k
ALLPLLepermislibre SA
0.397 €
(-11.78%)
3.01k
ATOAtos SE
0.0023 €
(-4.17%)
396.59M
BCPBanco Comercial Portugues SA
0.451 €
(0.16%)
17.85M
LATLatecoere
0.0094 €
(3.30%)
9.13M
ALVERVergnet
0.0021 €
(-4.55%)
8.37M
ALEUPEuroplasma
0.0484 €
(28.38%)
6.54M

Discussion

View Full Feed
Ringrock Ringrock 3 minutes ago
https://buildonhybrid.com/about

These are the developers, from what I understand 100,000 Otto gets you full access…
rx7171 rx7171 3 minutes ago
The potential revenue makes my head spin.

For Europe alone, 7 million current AD patients.
50% treatable = 3.5 million.
$5,000/yr = $17.5 billion gross revenue.
PLUS US equal revenue PLUS the rest of the world.

Roughly $50 billion gross by the third
AVXL
delerious1 delerious1 3 minutes ago
"Stocks that trade on over-the-counter (OTC) exchanges are a prime target for risk-tolerant investors. The penny stocks that trade OTC can be highly volatile, and it’s not uncommon for them to see double-digit gains in a single day."
NBRI
Horseb4CarT Horseb4CarT 4 minutes ago
There is poetic justice and then there's your justice poetic!!! Powerful message !

Thank you and best wishes to you and yours, and all!
NWBO
Brooge warrants cancelled Brooge warrants cancelled 4 minutes ago
never for over a decade
FNMA
delerious1 delerious1 7 minutes ago
Once we get some solid news and the stock starts to run the brokers that have been playing here with their HFT's will likely have to back off....then we will be off and running...
NBRI
PonkenPlonken PonkenPlonken 7 minutes ago
What is "funny" is that this guy got rich off of a scammy biotech stock newsletter.
The people will follow the mediocre ideas (its content really) from his newsletter but they wont follow his 9.99% stake filing in ASMB LOL.

He is a sleazeball, likely quasi insider trading here.
ASMB
Demolition Man Demolition Man 7 minutes ago
Merry Christmas all!! Let’s turn this ship around and lose several zeros in 2025!! If $KYNC and $AABB market the new digital wallet in any way we got a 5,000x-10,000 % banger at camp KYNC!! Let’s end next year this time at .05+ a share!!
AABB KYNC
Brooge warrants cancelled Brooge warrants cancelled 8 minutes ago
these estimates are way off
FNMA
glenn1919 glenn1919 8 minutes ago
STBX.......SATL.....ALBT.......IHRT......NCRA...................https://stockcharts.com/h-sc/ui?s=STBX&p=D&yr=0&mn=2&dy=12&id=p84071410134
ALBT IHRT NCRA
cowtown jay cowtown jay 9 minutes ago
cowtown jay

Re: dloggold post# 43602

Wednesday, December 25, 2024 11:54:38 AM

Post#
43603
of 43603
"...who in the federal system is going to get some money back to shareholders?" That should be the SEC, according to their charter,
georgie18 georgie18 9 minutes ago
BNRG...$1.05...🥳...Looking for a Break/Hold of the 200ma in the $1.20 range...If we get that then we see $1.50 range...if we cannot hold the 200ma then I think we see .90 range again as we wait for another attempt...

https://schrts.co/MwhxEfEp
BNRG
poster44ny poster44ny 9 minutes ago
Book Orders are being accepted again:

https://www.amazon.com/dp/B0DR84YM8H
HHSE
th6565 th6565 10 minutes ago
I think it was TZ as CEO of LWLG that “computing on polymers” was dropped.
LWLG
trailblazin trailblazin 13 minutes ago
Merry Xmas!!
COOP
georgie18 georgie18 13 minutes ago
PL...$4.14...🥳...Cup N Handle continuation Pattern setting up here...Handle is forming...If the Pattern succeeds then we see $8 plus...The Target is based on $1.70 bottom minus the top of the Cup which is $5 equals $3.70...we add the difference which is $3.70 to the top of the cup which equa
glenn1919 glenn1919 13 minutes ago
ORKT.......HOUR........TKNO.......NRXP........https://stockcharts.com/h-sc/ui?s=HOUR&p=D&yr=0&mn=2&dy=12&id=p84071410134
NRXP ORKT TKNO
glenn1919 glenn1919 15 minutes ago
KULR......ONCY........PRZO.........TVGN.....................https://stockcharts.com/h-sc/ui?s=KULR&p=D&yr=0&mn=2&dy=12&id=p84071410134
KULR ONCY PRZO
jimr1717 jimr1717 16 minutes ago
It would only be a Fool that would think this no company fraud has shorts.
CRSM
cowtown jay cowtown jay 16 minutes ago
"...who in the federal system is going to get some money back to shareholders?" That should be the SEC, according to their charter, if Dale is found guilty. But I already mentioned Pam Bondi. I also mentioned Ken Paxton for Texans, like me. But perhaps even more effectively acting on this case w
PonkenPlonken PonkenPlonken 16 minutes ago
nice Gilead double down
https://www.globenewswire.com/news-release/2024/12/19/2999793/16259/en/Assembly-Biosciences-Announces-30-1-Million-Equity-Investment-and-Accelerated-Funding-from-Gilead-to-Advance-Clinical-Development-Programs.html
ASMB
le-bon ton-roule le-bon ton-roule 16 minutes ago
Merry Christmas...IBAT is mentioned as one of the Key Players in the DLE Sector
Several companies and startups are leading the charge in advancing and commercializing DLE technology:
International Battery Metals (IBAT)
Utilizes proprietary sorbents within a modular, mobile plant
IBATF
Doktornolittle Doktornolittle 17 minutes ago
These issues do beg scrutinizing the reduced brain shrinkage data. What I read stated "reduced atrophy" which sounds pretty straight forward to me. More straight forward than just reduced mass which gets complicated for the stated reasons. But I should read this carefully in the company PR and in
AVXL
georgie18 georgie18 18 minutes ago
NEOV...$4.74...🥳...Bullish Pole N Flag Breakout setting up here...NEOV...manufactures ESS...Energy Storage Systems...Recently signed an LOI with XPON...Float in the 30 Million Range...Bollinger Bands Tightening up...

https://schrts.co/SFkcRhYg
NEOV XPON
glenn1919 glenn1919 19 minutes ago
TOVX......INVZ.....AQB......IDAI.....RVPH.......ASST......https://stockcharts.com/h-sc/ui?s=ASST&p=D&yr=0&mn=2&dy=12&id=p84071410134
AQB IDAI INVZ

Your Recent History

Delayed Upgrade Clock